Document is current
Any future updates will be listed below
-
Authors
Kontro, M
Kumar, A
Majumder, M M
Eldfors, S https://orcid.org/0000-0001-5056-4750
Parsons, A
Pemovska, T
Saarela, J
Yadav, B
Malani, D
Fløisand, Y
Höglund, M
Remes, K
Gjertsen, B T
Kallioniemi, O https://orcid.org/0000-0002-3231-0332
Wennerberg, K
Heckman, C A
Porkka, K
- License Information
-
More Information
Article History
Received: 2 March 2016
Revised: 1 July 2016
Accepted: 15 July 2016
First Online: 8 August 2016
Competing interests
: CAH has received research funding from Celgene and Pfizer; BTG has received research funding from Boehringer-Ingelheim Norge AS, and has been on advisory board for BerGenBio AS, Pfizer, Ariad, and Roche; MH has been on advisory boards for Janssen-Cilag and Akinion Pharmaceuticals; KP has received research funding from Celgene; and KW has received research funding from Pfizer.
